ASHLEY BRANDMIER: Open Payments
NPI 1730890534 · STERLING HEIGHTS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$329 in 15 payments from 11 companies in 2025. Trend: 2023 $125 · 2024 $883 · 2025 $329
Food & beverage: $329
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $61 |
| Travere Therapeutics, Inc. | 2 | $44 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $34 |
| Calliditas Therapeutics US Inc. | 1 | $32 |
| Vifor Pharma, Inc. | 1 | $28 |
| Alexion Pharmaceuticals, Inc. | 1 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Ardelyx, Inc. | 1 | $21 |
| Aurinia Pharma U.S., Inc. | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
Products named: Kerendia, TARPEYO, Veltassa, ULTOMIRIS, JYNARQUE, IBSRELA, LUPKYNIS, JARDIANCE.
Industry payments across MI — which companies pay providers there.
